Influenza vaccine, cell-derived
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza vaccine, cell-derived, covering 2013-10-25 to 2013-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination [Phase 2]